May 2, 2026 by Geoffrey SeilerBull vs. Bear: Is Intel Stock a Buy or Sell?Looking at the bullish and bearish cases for Intel.
May 2, 2026 by Adam LevyFed Chair Nominee Kevin Warsh Disagrees With Jerome Powell on This Key Fed Policy Supporting the Stock Market (Hint: Not Rate Cuts)A major change in monetary policy could have wide-ranging impacts on investors.
May 2, 2026 by Brett SchaferOil Prices Just Crossed $100 Again. Here's What Energy Investors Should Do Next.Oil prices are going to drive profits for the sector, specifically in North America.
May 2, 2026 by Will HealyInvestors Should Buy the Stocks of These 3 OpenAI Partners Regardless of What Happens to OpenAIAmazon, CoreWeave, and Oracle can thrive with or without deals from OpenAI.
May 2, 2026 by Geoffrey SeilerBull vs. Bear: Is Intel Stock a Buy or Sell?Looking at the bullish and bearish cases for Intel.
May 2, 2026 by Steven PorrelloIf You'd Invested $10,000 in Bloom Energy One Year Ago, Here's How Much You'd Have TodayBloom Energy has notched a four-digit gain since last year, making it one of the most dominant clean energy companies on the market today.
May 2, 2026 by Adam LevyFed Chair Nominee Kevin Warsh Disagrees With Jerome Powell on This Key Fed Policy Supporting the Stock Market (Hint: Not Rate Cuts)A major change in monetary policy could have wide-ranging impacts on investors.
May 2, 2026 by Brett SchaferOil Prices Just Crossed $100 Again. Here's What Energy Investors Should Do Next.Oil prices are going to drive profits for the sector, specifically in North America.
May 2, 2026 by John BallardMissed Advanced Micro Devices' Big Move? Here's Why It's Still a BuyCEO Lisa Su: Customers are "anxious" to get the MI450 GPU in their data centers.
May 2, 2026 by Lee SamahaHere's Why GE Healthcare Shares Slumped This WeekThe company's margins are coming under pressure in an inflationary environment.
May 2, 2026 by Reuben Gregg BrewerThe Energy Transition Isn't Dead. These 3 Renewable Stocks Are Built to Last Decades.The world is focused on oil, but don't forget about the ongoing shift toward cleaner alternatives.
May 2, 2026 by Matt DiLalloChevron's Production Soared Along With Oil Prices in the First Quarter, But Its Profits Fell. What Happened With the Oil Stock?Chevron faced some war-driven headwinds in the first quarter.
May 2, 2026 by Prosper Junior BakinyElon Musk Just Announced Fanastic News to Nvidia Stock InvestorsThese longtime market-beaters still have quite aggressive ambitions.
May 2, 2026 by Lyle DalyHere's Why I Wouldn't Touch Hyperliquid With a 10-Foot PoleThis decentralized exchange is growing quickly, but there are a few red flags investors should know about.
May 2, 2026 by David Jagielski, CPATilray Brands to Expand Into the U.S. Marijuana Market? Why You Shouldn't Count on That Anytime SoonMarijuana rescheduling may have taken place in the U.S., but that doesn't mean legalization will happen anytime soon.
May 2, 2026 by James BrumleyIf the Market Crashes, I'm Buying These 3 Stocks Before the Dust SettlesWindows of opportunity usually aren't open for very long. To act in time, you'll want to plan ahead.
May 2, 2026 by Thomas NielLemonade Has Momentum, but Investors Need More Than GrowthOther key metrics for Lemonade are also improving.
May 2, 2026 by John BallardMissed Dell's Big Move? These AI Stocks Could Be Next.These stocks have been consolidating ahead of a potential breakout.
May 2, 2026 by Daniel SparksHere's the Real Problem With Meta's Latest Earnings ReportThe headlines blame the spending plan. But I think there's an even bigger concern.
May 2, 2026 by Cory RenauerA Penguin Solutions (PENG) Insider Sold 6,485 Shares for $190,000This diversified tech provider for data-driven industries reported a notable insider sale amid a year of strong share price gains.
May 2, 2026 by Christy BieberDoes Your 401(k) Balance Beat the Average Millennial's?It can be helpful to see how your 401(k) compares with others so you can get an idea of where you stand.
May 2, 2026 by Courtney CarlsenFluor Has Finished Selling Its NuScale Power Stock. You Won't Believe How Much It Made.Fluor was an early investor in NuScale Power in 2011.
May 2, 2026 by James HalleyIs Regeneron a Buy After the FDA Approved its Gene Therapy to Restore Hearing?Regeneron is seeing double-digit revenue growth and has more than 50 therapies in its pipeline, making it a good long-term investment.
